These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 4870320)
1. Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections. Boyer JL; Andriole VT Yale J Biol Med; 1968 Feb; 40(4):284-95. PubMed ID: 4870320 [No Abstract] [Full Text] [Related]
2. Laboratory and clinical evaluation of rifampicin. Atlas E; Turck M Am J Med Sci; 1968 Oct; 256(4):47-54. PubMed ID: 4387028 [No Abstract] [Full Text] [Related]
3. [Effect of gentamicin and other therapeutic drugs on the causative agents in urinary tract infections. 10-year report]. Schmid W Med Welt; 1980 Jan; 31(1):32-6. PubMed ID: 6770223 [No Abstract] [Full Text] [Related]
4. Cephaloglycin. Clinical and laboratory experience with an orally administered cephalosporin. Johnson WD; Applestein JM; Kaye D JAMA; 1968 Dec; 206(12):2698-702. PubMed ID: 4386947 [No Abstract] [Full Text] [Related]
5. Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic. Levison ME; Johnson WD; Thornhill TS; Kaye D JAMA; 1969 Sep; 209(9):1331-6. PubMed ID: 4895869 [No Abstract] [Full Text] [Related]
6. [Sensitivity to some antibacterial agents, of the microbial flora isolated from patients with infections of the urinary tract in the years 1964-1967]. Diana L; Romano M; Perin G Ig Mod; 1968; 61(5):292-315. PubMed ID: 4889607 [No Abstract] [Full Text] [Related]
7. Cephalothin: antibacterial activity in vitro and treatment of infections in man. Altucci P; Sapio U; Varone GL Chemotherapy; 1967; 12(2):89-100. PubMed ID: 4383219 [No Abstract] [Full Text] [Related]
8. [Study of nalidixic acid activity on 3186 strains of Gram negative bacilli. Application to the treatment of urinary infections]. Chamfeuil R; Curcier H Presse Med (1893); 1969 Nov; 77(48):1763-4. PubMed ID: 4903534 [No Abstract] [Full Text] [Related]
9. [Treatment of urinary tract infections with cephalexin an oral antibiotic of cephalosporin-group]. Hofmeister H; Scharrer G; Sawallisch R Arzneimittelforschung; 1970 Jan; 20(1):139-42. PubMed ID: 4986282 [No Abstract] [Full Text] [Related]
10. Evaluation of phosphonomycin, a new cell wall-active antibiotic. Clark H; Brown NK; Wallace JF; Turck M Antimicrob Agents Chemother (Bethesda); 1969; 9():338-42. PubMed ID: 4990371 [No Abstract] [Full Text] [Related]
11. Clinical and laboratory evaluation of cephalexin in urinary-tract infections. Acar JF; Baudens JG; Chabbert YA Antimicrob Agents Chemother (Bethesda); 1969; 9():398-404. PubMed ID: 4919001 [No Abstract] [Full Text] [Related]
13. [Bacterial agents responsible for urinary tract infections. III. A clinico-statistical contribution]. Roscioni C; Pennelli GM; Monaco G; Roscioni MC Clin Ter; 1988 Aug; 126(3):207-15. PubMed ID: 2974387 [No Abstract] [Full Text] [Related]
14. [In vitro sensitivity of gram-negative bacteria isolated from urinary tract infections to various antibiotics]. KiliƧ H; Karahan M Mikrobiyol Bul; 1991 Jan; 25(1):28-35. PubMed ID: 1881356 [TBL] [Abstract][Full Text] [Related]
15. [Clinical and bacteriological studies on the course of 31 cases of most severe chronic urinary tract infections during mainly discordant cephalexin medication]. Breitfellner G; Gasser G; Hauke D Schweiz Rundsch Med Prax; 1973 Mar; 62(12):366-78. PubMed ID: 4570646 [No Abstract] [Full Text] [Related]
16. [Hospitalism in urology]. Lipsky H Med Klin; 1970 Oct; 65(42):1833-8. PubMed ID: 4997048 [No Abstract] [Full Text] [Related]
17. Transferable R factors in enteric bacteria causing infection of the genitourinary tract. Smith DH; Armour SE Lancet; 1966 Jul; 2(7453):15-8. PubMed ID: 4161048 [No Abstract] [Full Text] [Related]
18. Tobramycin: clinical and microbiological evaluation. Schoutens E; Vanderlinden MP; Yourassowsky E Int J Clin Pharmacol; 1973 Nov; 8(3):207-15. PubMed ID: 4589328 [No Abstract] [Full Text] [Related]